INSIGHTS ON CLINICAL TRIAL DESIGN

• Effective Study Design And Execution Of Renal And Hepatic Impairment Trials

  Master the complexities of renal and hepatic trials by leveraging site expertise and PK modeling to navigate recruitment challenges and ensure precise dosing for impaired populations.

• Key Risk Areas that Can Derail Clinical Trials with Ocular Endpoints

  By embracing point-of-need models and strategic collaborations, sponsors and CROs can streamline ophthalmic trials and maximize ROI while advancing sight-saving therapies.

• On-site ePRO Solutions For Flexible Data Collection Across Devices

  Optimize flexible electronic patient-reported outcomes that allow participants to switch between site-owned devices, personal hardware, and remote completion.

• The Importance Of A Maturity Model For Clinical Trial Transparency

  A comprehensive maturity model for clinical trial disclosure and transparency offers companies a strategic tool to assess and enhance their practices in an increasingly complex regulatory environment.

• Evaluating Adaptive Trials: Do They Align With Your Study's Goals?

  4/10/2025

  In this short video as Robin Bliss, Vice President, Strategic Consulting at Veristat, shares four key questions that she likes to ask when planning an adaptive design clinical trial.

• Optimizing Pharmacokinetics In Clinical Development

  8/24/2026

  PK tools can do more than model drug behavior — they shape smarter trial designs, better dosing decisions, and lighter burdens on patients. Here's how.

• What Everest Group's RTSM Recognition Means For The Industry

  12/5/2025

  RTSM is transforming from a basic operational tool into a strategic driver of trial efficiency. Learn why industry recognition signals a new era of innovation and competitive advantage.

• Vendor Selection Bias: Why Structured Decisions Often Fail

  12/22/2025

  Learn how subtle influences derail decisions and discover proven safeguards that promote transparency, accountability, and shared ownership for better trial outcomes.

• Unlocking Recruitment Potential In Trial-Naïve Sites

  4/17/2025

  Site Professional Support enabled this late-phase rheumatoid arthritis study to conduct complex patient visits despite its use of sites that lacked research experience and resources.